Forma Therapeutics Holdings Inc (OQ:FMTX)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for FMTX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET July 4th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jun 25/20 Jun 23/20 Wellington Biomedical Innovation Master Investors (Cayman) I L.P. Direct Ownership Series D Convertible Preferred Stock C - Conversion -5,359,344  
Jun 25/20 Jun 23/20 Wellington Biomedical Innovation Master Investors (Cayman) I L.P. Direct Ownership Common Stock P - Open market or private purchase 1,000,000 $20.00
Jun 25/20 Jun 23/20 Wellington Biomedical Innovation Master Investors (Cayman) I L.P. Direct Ownership Common Stock C - Conversion 1,252,913  
Jun 24/20 Jun 23/20 Ra Capital Management, L.P. Indirect Ownership Series D Redeemable Convertible Preferred Stock C - Conversion -21,437,376  
Jun 24/20 Jun 23/20 Ra Capital Management, L.P. Indirect Ownership Common Stock P - Open market or private purchase 4,000,000 $20.00
Jun 24/20 Jun 23/20 Ra Capital Management, L.P. Indirect Ownership Common Stock C - Conversion 5,011,651  
Jun 24/20 Jun 23/20 Wirth Peter Direct Ownership Enterprise 5 Junior Stock S - Open market or private sale -14,026  
Jun 24/20 Jun 23/20 Wirth Peter Direct Ownership Enterprise 4 Junior Stock S - Open market or private sale -10,240  
Jun 24/20 Jun 23/20 Wirth Peter Direct Ownership Enterprise 3 Junior Stock S - Open market or private sale -9,847  
Jun 24/20 Jun 23/20 Wirth Peter Direct Ownership Enterprise 2 Junior Stock S - Open market or private sale -18,585  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for FMTX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET July 4th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jun 25/20 Jun 23/20 Wellington Biomedical Innovation Master Investors (Cayman) I L.P. Direct Ownership Series D Convertible Preferred Stock C - Conversion -5,359,344  
Jun 25/20 Jun 23/20 Wellington Biomedical Innovation Master Investors (Cayman) I L.P. Direct Ownership Common Stock P - Open market or private purchase 1,000,000 $20.00
Jun 25/20 Jun 23/20 Wellington Biomedical Innovation Master Investors (Cayman) I L.P. Direct Ownership Common Stock C - Conversion 1,252,913  
Jun 24/20 Jun 23/20 Ra Capital Management, L.P. Indirect Ownership Series D Redeemable Convertible Preferred Stock C - Conversion -21,437,376  
Jun 24/20 Jun 23/20 Ra Capital Management, L.P. Indirect Ownership Common Stock P - Open market or private purchase 4,000,000 $20.00
Jun 24/20 Jun 23/20 Ra Capital Management, L.P. Indirect Ownership Common Stock C - Conversion 5,011,651  
Jun 24/20 Jun 23/20 Wirth Peter Direct Ownership Enterprise 5 Junior Stock S - Open market or private sale -14,026  
Jun 24/20 Jun 23/20 Wirth Peter Direct Ownership Enterprise 4 Junior Stock S - Open market or private sale -10,240  
Jun 24/20 Jun 23/20 Wirth Peter Direct Ownership Enterprise 3 Junior Stock S - Open market or private sale -9,847  
Jun 24/20 Jun 23/20 Wirth Peter Direct Ownership Enterprise 2 Junior Stock S - Open market or private sale -18,585  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $FMTX

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Biohaven Pharmaceutical H (N:BHVN)
Seattle Genetics (OQ:SGEN)